NFE2L2 and neoplasm: The most robust effort to date, an analysis of over 1,000 tumors across 10 tumor subtypes using CPTAC proteogenomics data, identified that mutations in Keap1 and NRF2 were associated with diminished IFNγ and CD8 T cells [62].